Amgen Inc. | Pedestal Health

3

Total Publications

2

Abstract/Manuscript

1

Oral Presentation

2021 · Abstract/Manuscript · Pharma Partner

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice.

2020 · Abstract/Manuscript · Pharma Partner

Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States.

2018 · Oral Presentation · Pharma Partner · Methods/Pharmacoepi

Real-world patterns of romiplostim treatment in adults with primary immune thrombocytopenia in the United States.